These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 36515045)

  • 81. Optimized efflux assay for the NorA multidrug efflux pump in Staphylococcus aureus.
    Zimmermann S; Tuchscherr L; Rödel J; Löffler B; Bohnert JA
    J Microbiol Methods; 2017 Nov; 142():39-40. PubMed ID: 28887002
    [TBL] [Abstract][Full Text] [Related]  

  • 82. 1-(1H-indol-3-yl)ethanamine derivatives as potent Staphylococcus aureus NorA efflux pump inhibitors.
    Hequet A; Burchak ON; Jeanty M; Guinchard X; Le Pihive E; Maigre L; Bouhours P; Schneider D; Maurin M; Paris JM; Denis JN; Jolivalt C
    ChemMedChem; 2014 Jul; 9(7):1534-45. PubMed ID: 24677763
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Effect of Carvacrol and Thymol on NorA efflux pump inhibition in multidrug-resistant (MDR) Staphylococcus aureus strains.
    Dos Santos Barbosa CR; Scherf JR; de Freitas TS; de Menezes IRA; Pereira RLS; Dos Santos JFS; de Jesus SSP; Lopes TP; de Sousa Silveira Z; de Morais Oliveira-Tintino CD; Júnior JPS; Coutinho HDM; Tintino SR; da Cunha FAB
    J Bioenerg Biomembr; 2021 Aug; 53(4):489-498. PubMed ID: 34159523
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Mutagenesis and modeling to predict structural and functional characteristics of the Staphylococcus aureus MepA multidrug efflux pump.
    Schindler BD; Patel D; Seo SM; Kaatz GW
    J Bacteriol; 2013 Feb; 195(3):523-33. PubMed ID: 23175649
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Tripartite efflux pumps of the RND superfamily: what did we learn from computational studies?
    Athar M; Gervasoni S; Catte A; Basciu A; Malloci G; Ruggerone P; Vargiu AV
    Microbiology (Reading); 2023 Mar; 169(3):. PubMed ID: 36972322
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Potentiating activity of Norfloxacin by synthetic chalcones against NorA overproducing Staphylococcus aureus.
    Alves Borges Leal AL; Teixeira da Silva P; Nunes da Rocha M; Marinho EM; Marinho ES; Marinho MM; Bandeira PN; Sampaio Nogueira CE; Barreto HM; Rodrigues Teixeira AM; Silva Dos Santos H
    Microb Pathog; 2021 Jun; 155():104894. PubMed ID: 33894291
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Synthesis, antibiotic modifying activity, ADMET study and molecular docking of chalcone (E)-3-(2,4-dichlorophenyl)-1-(2-hydroxyphenyl)prop-2-en-1-one in strains of Staphylococcus aureus carrying MepA efflux pumps.
    Rocha JE; de Freitas TS; da Cunha Xavier J; Pereira RLS; Pereira FN; Nogueira CES; Marinho MM; Bandeira PN; Fernandes MAA; Marinho ES; Teixeira AMR; Dos Santos HS; Coutinho HDM
    Arch Microbiol; 2021 Dec; 204(1):63. PubMed ID: 34940944
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Occurrence and Variability of the Efflux Pump Gene
    Ferreira C; Abrantes P; Costa SS; Viveiros M; Couto I
    Int J Mol Sci; 2022 Dec; 23(23):. PubMed ID: 36499632
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Liposome evaluation in inhibiting pump efflux of NorA of Staphylococcus aureus.
    Júnior JGAS; Coutinho HDM; Rodrigues JPV; Ferreira VPG; Neto JBA; Costa da Silva MM; Justino de Araújo AC; Pereira RLS; Alexandre de Aquino PE; Oliveira-Tintino CDM; Nicolete R
    Chem Phys Lipids; 2022 Jul; 245():105204. PubMed ID: 35398337
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Antibacterial and antibiotic modifying activity, ADMET study and molecular docking of synthetic chalcone (E)-1-(2-hydroxyphenyl)-3-(2,4-dimethoxy-3-methylphenyl)prop-2-en-1-one in strains of Staphylococcus aureus carrying NorA and MepA efflux pumps.
    Rocha JE; de Freitas TS; da Cunha Xavier J; Pereira RLS; Junior FNP; Nogueira CES; Marinho MM; Bandeira PN; de Oliveira MR; Marinho ES; Teixeira AMR; Dos Santos HS; Coutinho HDM
    Biomed Pharmacother; 2021 Aug; 140():111768. PubMed ID: 34058442
    [TBL] [Abstract][Full Text] [Related]  

  • 91. First identification of boronic species as novel potential inhibitors of the Staphylococcus aureus NorA efflux pump.
    Fontaine F; Hequet A; Voisin-Chiret AS; Bouillon A; Lesnard A; Cresteil T; Jolivalt C; Rault S
    J Med Chem; 2014 Mar; 57(6):2536-48. PubMed ID: 24499135
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Novel insight into antimicrobial resistance and sensitivity phenotypes associated to qac and norA genotypes in Staphylococcus aureus.
    Marchi E; Furi L; Arioli S; Morrissey I; Di Lorenzo V; Mora D; Giovannetti L; Oggioni MR; Viti C
    Microbiol Res; 2015 Jan; 170():184-94. PubMed ID: 25081379
    [TBL] [Abstract][Full Text] [Related]  

  • 93. 2-Phenylquinoline S. aureus NorA Efflux Pump Inhibitors: Evaluation of the Importance of Methoxy Group Introduction.
    Felicetti T; Cannalire R; Pietrella D; Latacz G; Lubelska A; Manfroni G; Barreca ML; Massari S; Tabarrini O; Kieć-Kononowicz K; Schindler BD; Kaatz GW; Cecchetti V; Sabatini S
    J Med Chem; 2018 Sep; 61(17):7827-7848. PubMed ID: 30067360
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Pharmacophore-Based Repositioning of Approved Drugs as Novel Staphylococcus aureus NorA Efflux Pump Inhibitors.
    Astolfi A; Felicetti T; Iraci N; Manfroni G; Massari S; Pietrella D; Tabarrini O; Kaatz GW; Barreca ML; Sabatini S; Cecchetti V
    J Med Chem; 2017 Feb; 60(4):1598-1604. PubMed ID: 28117588
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Studies on 2-phenylquinoline Staphylococcus aureus NorA efflux pump inhibitors: New insights on the C-6 position.
    Felicetti T; Cannalire R; Nizi MG; Tabarrini O; Massari S; Barreca ML; Manfroni G; Schindler BD; Cecchetti V; Kaatz GW; Sabatini S
    Eur J Med Chem; 2018 Jul; 155():428-433. PubMed ID: 29908437
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Cholesterol and ergosterol affect the activity of Staphylococcus aureus antibiotic efflux pumps.
    Tintino SR; Oliveira-Tintino CD; Campina FF; Costa MS; Cruz RP; Pereira RL; Andrade JC; Sousa EO; Siqueira-Junior JP; Coutinho HD; Leal-Balbino TC; Balbino VQ
    Microb Pathog; 2017 Mar; 104():133-136. PubMed ID: 28088472
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Dithiazole thione derivative as competitive NorA efflux pump inhibitor to curtail multi drug resistant clinical isolate of MRSA in a zebrafish infection model.
    Lowrence RC; Raman T; Makala HV; Ulaganathan V; Subramaniapillai SG; Kuppuswamy AA; Mani A; Chittoor Neelakantan S; Nagarajan S
    Appl Microbiol Biotechnol; 2016 Nov; 100(21):9265-9281. PubMed ID: 27531512
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Pseudomonas aeruginosa efflux pump superfamily (review of literature).
    Ivanov ME; Fursova NK; Potapov VD
    Klin Lab Diagn; 2022 Jan; 67(1):53-58. PubMed ID: 35077071
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Modulation of the Drug Resistance by
    E Silva AKF; Dos Reis AC; Pinheiro EEA; de Sousa JN; de Alcântara Oliveira FA; Moura AKS; de Sousa L Neto J; das Graças L Citó AM; Siqueira-Júnior JP; Kaatz GW; Barreto HM
    Curr Drug Metab; 2021; 22(2):114-122. PubMed ID: 32445452
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Stress impact of liposomes loaded with ciprofloxacin on the expression level of MepA and NorB efflux pumps of methicillin-resistant Staphylococcus aureus.
    Faraag AHI; Shafaa MW; Elkholy NS; Abdel-Hafez LJM
    Int Microbiol; 2022 Aug; 25(3):427-446. PubMed ID: 34822035
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.